Takeda Pharmaceutical

Takeda is a patient-focused, values-based, R&D-driven multinational biopharmaceutical business dedicated to providing people across the world with Better Health and a Brighter Future. Their commitment for potentially life-changing medicines for patients is profoundly founded in their remarkable history in Japan, which dates back to 1781.

It is Asia's largest pharmaceutical firm and one among the top 20 pharmaceutical companies in the world by revenue (top 10 after its merger with Shire). During the 2018 fiscal year, the corporation had around 49,578 people globally and sales of US$19.299 billion.

Oncology, rare illnesses, neuroscience, gastroenterology, plasma-derived medicines, and vaccines are the primary areas of focus for the organization.

Takeda's Global Headquarters in Nihonbashi, Tokyo, which opened in July 2018, serves as the headquarters for the company's global activities. Kashiwa Sato, one of the world's premier creative directors, created the interior of the building, which represents the essence of Takeda's principles and its basic commitment to always putting patients first.

Takeda Oncology Company was named one of the 100 greatest companies to work for in the United States by Fortune Magazine in January 2012. Christophe Weber was named CEO and President of Takeda in 2015.

Founded: Doshomachi, Osaka, Japan (12 June 1781)

Founder: Chobei Takeda I

Headquarters: Nihonbashi, Chuo, Tokyo, Japan

Key people: Yasuchika Hasegawa, Christophe Weber

Website: https://www.takeda.com/